CONMED Corp Annual Deferred Income Tax Expense (Benefit) in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
CONMED Corp annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • CONMED Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $1.87M.
  • CONMED Corp annual Deferred Income Tax Expense (Benefit) for 2024 was $12.2M, a 1643% increase from 2023.
  • CONMED Corp annual Deferred Income Tax Expense (Benefit) for 2023 was $700K.
  • CONMED Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$6.04M, a 301% decline from 2021.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.2M +$11.5M +1643% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-18
2023 $700K +$6.74M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-18
2022 -$6.04M -$9.05M -301% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-18
2021 $3.01M +$17.2M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$14.2M -$7.92M -126% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 -$6.31M -$8.37M -406% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $2.06M +$42.1M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-22
2017 -$40M -$37.2M -1294% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 -$2.87M -$5.12M -228% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 $2.25M +$2.54M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-26
2014 -$284K -$7.5M -104% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $7.22M -$5.73M -44.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $12.9M +$26M Jan 1, 2012 Dec 31, 2012 10-K 2015-02-23
2011 -$13.1M -$26.3M -200% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-24
2010 $13.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.